Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | suramin sodium | 8514 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | suramin sodium | 8514 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | suramin sodium | 8514 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | suramin sodium | 8514 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | suramin sodium | 8514 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | suramin sodium | 8514 | drug-path |
Glioma | Q9NZM4 | map05214 | suramin sodium | 8514 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | caffeic acid | 29327 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | caffeic acid | 29327 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | caffeic acid | 29327 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | desoxycortone | 6166 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | desoxycortone | 6166 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | rolipram | 5092 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | rolipram | 5092 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | rolipram | 5092 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | rolipram | 5092 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | rolipram | 5092 | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | idazoxan | 55245 | drug-path |
Wnt signaling pathway | R-HSA-195721 | map04310 | idazoxan | 55245 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | idazoxan | 55245 | drug-path |